About Alzamend Neuro Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://alzamend.com/
Frequently Asked Questions
What is the 52-week range for ALZN?
The 52-week high is $2.68 and the 52-week low is $0.84.
What is the P/E ratio for ALZN?
The P/E ratio data is currently unavailable.
What is the dividend yield for ALZN?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -277.88%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 5.92.
Analyst Recommendation Trends
Wall Street analyst consensus for ALZN over the last few months:
Latest ALZN News
Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?
Here is how Centene (CNC) and Alzamend Neuro, Inc. (ALZN) have performed compared to their sector so far this year.
Alzamend Neuro Regains Compliance with Nasdaq Listing Standards
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major depressive disorder ("MDD") and post-traumatic stress disorder ("PTSD"), today announced that it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Staff of the Nasdaq Stock Market, LLC ("Nasdaq") dated September 14, 2026, informing Alzame
Alzamend Neuro Regains Nasdaq Compliance
Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar
Alzamend Neuro Q1 EPS $(0.68) Misses $(0.56) Estimate, Sales $0.00, Same YoY
Alzamend Neuro (NASDAQ:ALZN) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.56) by 21.43 percent. This is a 46.88 percent increase over losses of $(1.28) per share from
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-08-26 | AULT MILTON C III | -2,000 | $1.5581 | $3,116 |
| 2026-07-31 | Hyperscale Data, Inc. | +7,500 | $1000 | $7,500,000 |
| 2026-07-31 | Hyperscale Data, Inc. | +7,500 | $1000 | $7,500,000 |
| 2026-07-31 | AULT MILTON C III | +7,500 | $1000 | $7,500,000 |
| 2026-04-14 | AULT MILTON C III | +2,000 | $1.0338 | $2,068 |
| 2026-04-14 | AULT MILTON C III | +108,388 | $1.0047 | $108,897 |
| 2026-04-14 | AULT MILTON C III | +2,000 | $1.0338 | $2,068 |
| 2026-04-14 | AULT MILTON C III | +108,388 | $1.0047 | $108,897 |
| 2026-04-14 | AULT MILTON C III | +108,388 | $1.0047 | $108,897 |
| 2025-12-23 | AULT MILTON C III | -1,851 | $2.0665 | $3,825 |
| 2025-12-19 | Horne William B. | -3,333 | $2.1178 | $7,059 |
| 2025-10-23 | McGrath Lynne Fahey | -30 | $2.29 | $69 |
| 2025-10-09 | AULT MILTON C III | -20,397 | $2.3234 | $47,390 |
| 2025-10-08 | AULT MILTON C III | -143 | $1000 | $143,000 |
| 2025-10-08 | AULT MILTON C III | -101,394 | $2.4376 | $247,158 |
| 2025-10-08 | AULT MILTON C III | +61,743 | $2.32 | $143,244 |
| 2025-10-07 | AULT MILTON C III | -232 | $1000 | $232,000 |
| 2025-10-07 | AULT MILTON C III | -57,379 | $2.4914 | $142,954 |
| 2025-10-07 | AULT MILTON C III | +100,000 | $2.32 | $232,000 |
| 2025-10-06 | AULT MILTON C III | -82,033 | $2.4535 | $201,268 |
| 2025-10-03 | AULT MILTON C III | -232 | $1000 | $232,000 |
| 2025-10-03 | AULT MILTON C III | +100,000 | $2.32 | $232,000 |
| 2025-10-03 | AULT MILTON C III | -65,903 | $2.4413 | $160,889 |